Single peptide Vial strength 5 mg
Mazdutide5 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Mazdutide, explained simply
A compound studied in weight management and type 2 diabetes research.
Research area
Weight, blood glucose and energy metabolism
How it works
Acts at GLP-1 and glucagon receptors, combining signals involved in appetite, glucose control and energy expenditure.
Why it matters
It allows comparison of dual agonism with therapies acting mainly through GLP-1 alone.
What has been observed
Phase 2 and 3 clinical studies report weight and glycaemic outcomes in defined populations.
Effects and points to consider
Gastrointestinal events occur in the cited studies; indication, formulation and regulatory status require context-specific assessment.
01 / Vial strength 5 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 5 mg Mazdutide |
|---|---|
| Final volume | 3 mL |
| Concentration | 1.67 mg/mL |
| One U-100 unit | 16.67 mcg in 0.01 mL |
Standard / Gradual Titration (3.0 mL = ~1.67 mg/mL)
| Week | Weekly Dose | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–4 | 2.5 mg (2,500 mcg) | 150 units (1.50 mL) |
| Weeks 5–8+ | 5 mg (5,000 mcg) | 300 units (3.00 mL) |
Advanced / High‑Dose Protocol (2.0 mL = 2.5 mg/mL)
| Week | Weekly Dose | Units (per injection) (mL) | Notes |
|---|---|---|---|
| Weeks 1–4 | 5 mg (5,000 mcg) | 200 units (2.00 mL) | 1 vial |
| Weeks 5–8 | 7.5 mg (7,500 mcg) | 300 units (3.00 mL) | 1.5 vials |
| Weeks 9–12+ | 10 mg (10,000 mcg) | 400 units (4.00 mL) | 2 vials; split into 2 injections |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.